Cost-Effectiveness Analysis of First-Line Treatment With Biologic Agents in Polyarticular Juvenile Idiopathic Arthritis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Cost-Effectiveness Analysis of First-Line Treatment With Biologic Agents in Polyarticular Juvenile Idiopathic Arthritis

Published:2016-10-21 Issue:12 Volume:68 Page:1803-1811
ISSN:2151-464X
Container-title:Arthritis Care & Research
language:en
Short-container-title:Arthritis Care & Research

Author:

Luca Nadia J.¹,Burnett Heather F.²,Ungar Wendy J.²,Moretti Myla E.²,Beukelman Timothy³,Feldman Brian M.²,Schwartz Gwen⁴,Bayoumi Ahmed M.⁴

Affiliation:

1. Alberta Children's Hospital and University of Calgary; Calgary Alberta Canada

2. The Hospital for Sick Children and University of Toronto; Toronto Ontario Canada

3. University of Alabama at Birmingham

4. St. Michael's Hospital; Toronto Ontario Canada

Funder

Ontario Ministry of Health and Long-Term Care Drug Innovation Fund and by the Hospital for Sick Children

Publisher

Wiley

Subject

Rheumatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/acr.22903/fullpdf

Reference50 articles.

1. Juvenile idiopathic arthritis;Ravelli;Lancet,2007

2. Early outcomes and improvement of patients with juvenile idiopathic arthritis enrolled in a Canadian multicenter inception cohort;Oen;Arthritis Care Res (Hoboken),2010

3. Economic impact of juvenile idiopathic arthritis;Bernatsky;Arthritis Rheum,2007

4. Cost-effectiveness of biologics in polyarticular-course juvenile idiopathic arthritis patients unresponsive to disease-modifying antirheumatic drugs;Ungar;Arthritis Care Res (Hoboken),2011

5. 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features;Beukelman;Arthritis Care Res (Hoboken),2011

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-World Health Care Outcomes and Costs Among Patients With Juvenile Idiopathic Arthritis in Spain;Journal of Health Economics and Outcomes Research;2023-12-20

2. Real-World Health Care Outcomes and Costs Among Patients With Juvenile Idiopathic Arthritis in Spain;Journal of Health Economics and Outcomes Research;2023-12-20

3. Economic evaluation of infliximab, synthetic triple therapy and methotrexate in the treatment of newly diagnosed juvenile idiopathic arthritis;Pediatric Rheumatology;2022-11-16

4. Pharmacological treatment patterns in patients with juvenile idiopathic arthritis in the Netherlands: a real-world data analysis;Rheumatology;2022-05-18

5. Biologic medicine inclusion in 138 national essential medicines lists;Pediatric Rheumatology;2021-09-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3